Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ?3,395 crore offer is entirely for sale by existing shareholders, with proceeds going to them. Allocation includes 50% for QIBs, 15% for NIIs, and 35% for retail investors.
Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ?3,395 crore offer is entirely for sale by existing shareholders, with proceeds going to them. Allocation includes 50% for QIBs, 15% for NIIs, and 35% for retail investors.